Abstract:Objective: Several novel fluorinated chalcone derivatives were synthesized, and their in vitro anticervical cancer activity and mechanism of action were investigated using the parent nucleus of licorice chalcone as the lead compound backbone and MDM2-p53 as the target. Methods: In this study, 16 novel chalcone derivatives (3a–3r) were designed and synthesized by molecular docking technology based on the licorice chalcone parent nucleus as the lead compound scaffold and the cancer apoptosis regulatory target MDM2–p53. The structures of these compounds were confirmed by 1 H-NMR, 13 C-NMR, and HR-ESI-MS. The inhibitory effects of the compounds on the proliferation of three human cervical cancer cell lines (SiHa, HeLa, and C-33A) and two normal cell lines (H8 and HaCaT) were determined by MTT assay, and the initialstructure–activity relationship was analyzed. Transwell and flow cytometry were used to evaluate the effects of target compounds on the inhibition of cancer cell migration and invasion, apoptosis induction, and cell cycle arrest. Quantitative real-time polymerase chain reaction (qRT-PCR) and Western blot (WB) were used to detect the effects of candidate compounds on mRNA, p53, and Murine double minute 2 (MDM2) protein expression. The binding characteristics of the target compounds to the MDM2 protein target in the p53–MDM2 pathway were evaluated by molecular docking technology. Results:The target compounds had considerable inhibitory activity on the proliferation of three cervical cancer cell lines. Among them, compound 3k (E)-3-(4-(dimethylamino)phenyl)-2-methyl-1-(3-(trifluoromethyl)phenyl) prop-2-en-1-one) showed the highest activity against HeLa cells (IC 50 =1.08 μmol/L), which was better than that of the lead compound Licochalcone B, and 3k showed lower toxicity to both normal cells. Compound 3k strongly inhibited the migration and invasion of HeLa cells and induced apoptosis and cell cycle arrest at the G 0 /G 1 phase. Furthermore, compound 3k upregulated the expression of p53 and BAX and downregulated the expression of MDM2, MDMX, and BCL2. Moreover, molecular docking results showed that compound 3k could effectively bind to the MDM2 protein (binding energy: −9.0 kcal/mol). These results suggest that the compounds may activate the p53 signaling pathway by inhibiting MDM2 protein, which prevents cancer cell proliferation, migration, and invasion and induces apoptosis and cell cycle arrest in cancer cells. Conclusion: This study provides a new effective and low-toxicity drug candidate from licochalcone derivatives for treating cervical cancer.

Antiproliferative Evaluation in Vitro of a New Chalcone Inducing Apoptosis by ROS Generation Against MGC-803 Cells

Apoptosis of SGC7901 Gastric Cancer Cell Induced by Cyanidin-3-glucoside

Synthesis and Biological Evaluation of Amino Chalcone Derivatives as Antiproliferative Agents

A novel chalcone derivative S17 induces apoptosis through ROS dependent DR5 up-regulation in gastric cancer cells

Influence of Curcumin,Glyinflanins and Chalcone on Biological Actions of Human MGC-803

Alpha, 2’-Dihydroxy-4,4’-dimethoxydihydrochalcone Inhibits Cell Proliferation, Invasion, and Migration in Gastric Cancer in Part Via Autophagy

Synthesis of Chalcone Derivatives: Inducing Apoptosis of HepG2 Cells via Regulating Reactive Oxygen Species and Mitochondrial Pathway.

Elementary Study of the Effect of Chalcone on Cellular Biological Behavior of Human Stomach Cancer BGC823

A novel chalcone derivative has antitumor activity in melanoma by inducing DNA damage through the upregulation of ROS products

The Induction of G2/M Phase Cell Cycle Arrest and Apoptosis by the Chalcone Derivative 1C in Sensitive and Resistant Ovarian Cancer Cells Is Associated with ROS Generation

Synthesis and biological evaluation of bis-chalcone conjugates containing lysine linker as potential anticancer agents

Synthesis, biological evaluation and mechanism study of chalcone analogues as novel anti-cancer agents

Design, Synthesis, anticancer evaluation and in silico studies of 2,4,6-trimethoxychalcone derivatives

Antiproliferative Evaluation of Novel 4-Imidazolidinone Derivatives as Anticancer Agent Which Triggers ROS-Dependent Apoptosis in Colorectal Cancer Cell

Design, Synthesis, and In vitro Anti-cervical Cancer Activity of a Novel MDM2-p53 Inhibitor Based on a Chalcone Scaffold

Schisantherin A Induces Cell Apoptosis Through ROS/JNK Signaling Pathway in Human Gastric Cancer Cells.

Design, synthesis, and ex vivo anti-drug resistant cervical cancer activity of novel molecularly targeted chalcone derivatives

Chlorogenic acid regulates apoptosis and stem cell marker-related gene expression in A549 human lung cancer cells

3D-QSAR Study on Chalcone Compounds Inhibiting the Growth of Human Breast Tumor Cell MCF-7

Synthesis and Anti-gastric Cancer Activity by Targeting FGFR1 Pathway of Novel Asymmetric Bis-chalcone Compounds

The Chalcone 2′‐hydroxy‐4′,5′‐dimethoxychalcone Activates Death Receptor 5 Pathway and Leads to Apoptosis in Human Nonsmall Cell Lung Cancer Cells